top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Recent Trends in Pharmaceutical Analytical Chemistry
Recent Trends in Pharmaceutical Analytical Chemistry
Autore Zacharis Constantinos K
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (166 p.)
Soggetto topico Research & information: general
Soggetto non controllato growth hormone
long-acting Fc-fusion recombinant human growth hormone
method validation
cell-based bioassay
reporter gene assay
pharmacokinetics
tissue distribution
alnustone
rats
LC-MS/MS
inflammatory bowel disease
fixed-dose combination
biomimetic chromatography
thiopurine immunosuppressants
folic acid
doxorubicin
hernandezine
pharmacokinetic study
drug-drug interaction
gardneramine
monoterpenoid indole alkaloid
memantine
rimantadine
amantadine
zone fluidics
o-phthalaldehyde
derivatization
stopped-flow
quality control
anwuligan
rat
optode
polyhexamethylene biguanide hydrochloride
lactone-rhodamine B
contact-lens detergent
dietary supplement
adulteration
low-field NMR
multivariate analysis
steroids
Partial Least Squares regression
in vitro permeability
predictive model
ketamine
norketamine
high throughput bar adsorptive microextraction
LVI-GC-MS(SIM)
urine
baricitinib
UPLC-MS/MS
irbersartan
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557427303321
Zacharis Constantinos K  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges
Rheumatoid Arthritis Therapy Reappraisal : Strategies, Opportunities and Challenges
Autore Müller Rüdiger
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (260 p.)
Soggetto topico Medicine
Soggetto non controllato rheumatoid arthritis
sleep
sleep disorders
pain
osteoporosis
fracture
fracture risk assessment tool
treat-to-target
certolizumab pegol
csDMARDs
glucocorticoids
intra-articular injections
DAS 28
ACR response
HAQ-DI
TNFα
golimumab
efficacy
tolerability
immunogenicity
methotrexate
posology
titration
oral route
subcutaneous route
bioavailability
effectiveness
periodontitis
periodontal disease
anti-citrullinated protein autoantibodies
rheumatoid factor
smoking
medication
Porphyromonas gingivalis
Rheumatoid arthritis
matrix metalloproteinase 3
infliximab
pharmacogenomics
anti-TNF
personalized medicine
baricitinib
disease-modifying antirheumatic drugs
pain perception
outcomes research
patient perspective
Rheumatoid Arthritis
therapy
DMARD
MTX
Tumor Necrosis Factor-Alpha Inhibitors
ankylosing spondylitis
biosimilar
switching
synovial fibroblasts
cytokine
osteoclast
herbal medicine
methylation
next-generation sequencing
recovery of function
fatigue
productivity
tofacitinib
oral
Th1.17
IL-17A
IFN-γ, CD73
adenosine
psoriatic arthritis
regulation
pseudoerosions
hand
foot
ultrasonography
radiography
computed tomography
magnetic resonance imaging
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Rheumatoid Arthritis Therapy Reappraisal
Record Nr. UNINA-9910557286503321
Müller Rüdiger  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui